Main take outs for me
- $20m cash on hand gets us a long way along the pipeline
- CR will be needed for larger phase 3 trial(s)
- BTX1702 COULD (REPEAT COULD) go straight to phase 3 if results stack up
- BTX 1801 results were very very good and surprised by SP drop
- Next 12 -18 months very exciting
- Not many BIO's with pipeline as extended as BOT
- Lot of external interest in what doing and potential for partnerships/licensing or T/O in future
Ann: Botanix Roadshow Presentation, page-9
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $633.5M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.8¢ | 35.0¢ | $741.1K | 2.110M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 931063 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 63299 | 2 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |